- Home
- PODD vs LII Comparison
PODD vs LII Comparison
Compare PODD & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PODD | LII |
|---|---|---|
| Founded | 2000 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1B | 17.4B |
| IPO Year | 2007 | 1999 |
Fundamental Metrics
Financial Performance| Metric | PODD | LII |
|---|---|---|
| Price | $304.01 | $511.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 12 |
| Target Price | $359.00 | ★ $605.18 |
| AVG Volume (30 Days) | ★ 765.6K | 451.7K |
| Earning Date | 11-06-2025 | 10-22-2025 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | N/A | ★ 12.46 |
| EPS | 3.45 | ★ 23.67 |
| Revenue | $2,521,800,000.00 | ★ $5,345,300,000.00 |
| Revenue This Year | $32.55 | N/A |
| Revenue Next Year | $20.39 | $7.34 |
| P/E Ratio | $88.24 | ★ $21.62 |
| Revenue Growth | ★ 27.11 | 3.77 |
| 52 Week Low | $230.05 | $443.19 |
| 52 Week High | $354.88 | $689.44 |
Technical Indicators
Market Signals| Indicator | PODD | LII |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 60.54 |
| Support Level | $303.20 | $481.60 |
| Resistance Level | $317.34 | $499.95 |
| Average True Range (ATR) | 13.12 | 14.23 |
| MACD | -2.82 | 6.58 |
| Stochastic Oscillator | 3.14 | 99.78 |
Price Performance
Historical ComparisonAbout PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.